" /> Surrogate Endpoint Biomarker - CISMeF





Preferred Label : Surrogate Endpoint Biomarker;

Alternative definition : CDISC: A response biomarker that is an endpoint used in clinical trials as a substitute for a direct measure of how a patient feels, functions, or survives. (NIH-FDA BEST (Biomarkers, Endpoints, and other Tools) Resource);

NCI Metathesaurus CUI : CL1920307;

Détails


Vous pouvez consulter :


Nous contacter.
30/07/2025


[Accueil] [Haut de page]

© CHU de Rouen. Toute utilisation partielle ou totale de ce document doit mentionner la source.